← brief for 2026-10-31 · Slowing decline

Association of SGLT2 Inhibitor Use with Leukocyte Telomere Length in Patients with Type 2 Diabetes Mellitus with and Without Chronic Kidney Disease

Key takeaways

This study looked at 100 people with type 2 diabetes. It checked if a common diabetes drug changed the length of telomeres, which are protective caps on our DNA. The study found a link between the drug and these DNA markers. However, this is an observational study, so it shows a connection but not proof that the drug causes the change.

Who did this work

Yanina Rebrova (Shupyk National Healthcare University of Ukraine) · Yanina A. Saienko (D. F. Chebotarev State Institute of Gerontology of the National Academy of Medical Sciences of Ukraine) · Kostiantyn K. Midlovets (D. F. Chebotarev State Institute of Gerontology of the National Academy of Medical Sciences of Ukraine) · Veronika Korcheva (Taras Shevchenko National University of Kyiv) · Boris Mankovsky (Shupyk National Healthcare University of Ukraine)

Source

Article · OpenAlex, CKD works · 2026-10-30
https://doi.org/10.3390/diabetology7110214